期刊文献+

正电子显像剂11C-匹兹堡化合物B的化学合成及其临床应用

Chemical synthesis and clinical application of a new positron imaging agent 11C- Pittsburgh compound- B
原文传递
导出
摘要 阿尔茨海默病(AD)是一种严重影响老年人生活质量的常见疾病。11C-匹兹堡化合物B(11C—PIB)作为新型β-淀粉样蛋白(Aβ)正电子显像剂,能够特异性地检出AD的特征性病理学改变,为AD的早期诊断、早期治疗乃至疗效评价提供了潜在的可能性。 Alzheimer disease(AD)seriously influenced the quality of life in elderly. As a new positron imaging agent binding with β-amyloid, 11C-Pittsburgh compound-B can specifically detect characteristic pathological changes of AD. It provides the potential possibility of early diagnosis and treatment, effect evaluation in AD.
出处 《国际放射医学核医学杂志》 2008年第3期158-161,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 11C-匹兹堡化合物B 阿尔茨海默病 体层摄影术 发射型计算机 11C-Pittsburgh compound-B Alzheimer disease Tomography, emission-computed
  • 相关文献

参考文献13

  • 1Mathis CA, Holt DP, Wang Y, et al. ^11C-labelled thioflavin-T analogues for amyloid plaques imaging in Alzheimer' s disease[J]. J Label Compd Radiopharm, 2001, 44( 1 ): 26-28.
  • 2Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of ^11C-labelled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents[J]. J Med Chem, 2003, 46(13): 2740-2754.
  • 3Wilson AA, Garcia A, Chestakova A, et al. A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer [^11C]6-OH- BTA-1[J]. J Label Compd Radiopharm, 2004, 47: 679-682.
  • 4Toyama H, Ye D, Ichise M, et al. PET imaging of brain with the β-amyloid probe, [^11C]6-OH-BTA-1, in a transgenic mouse of Alzheimer's disease[J]. Eur J Nucl Med Mol Imaging, 2005, 32(5): 593-600.
  • 5Klunk WE, Lopresti B J, Ikonomovic MD, et al. Binging of the positron emission tomography tracer Pittsburgh Compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain[J]. J Neurosci, 2005, 25 (46): 10598-10606.
  • 6Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B[J]. Ann Neurol, 2004, 55(3): 306-319.
  • 7Kemppainen NM, Aalto S, Wilson IA, et al. Voxel-based analysis of PET amyloid ligand [nC]PIB uptake in Alzheimer disease [J]. Neurology, 2006, 67(9): 1575-1580.
  • 8Mintun MA, Larossa GN, Sheline YI, et al. [^11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease [J]. Neurology, 2006, 67(3): 446-452.
  • 9Kemppainen NM, Aalto S, Wilson IA, et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment [J]. Neurology, 2007, 68(19): 1603-1606.
  • 10Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B[J]. J Cereb Blood Flow Metab, 2005, 25(11): 1528- 1547.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部